HCW Biologics Inc.

Introduction

This page provides a comprehensive analysis of the known insider trading history of Hing C Wong. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

See Highest Ranking Insiders
Companies with Reported Insider Positions

The SEC filings indicate Hing C Wong has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:HCWB / HCW Biologics Inc. Chief Executive Officer, Director, 10% Owner 501,911
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Hing C Wong. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases HCWB / HCW Biologics Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in HCWB / HCW Biologics Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares		 Reported
Price		 Adjusted
Shares		 Adjusted
Price		 Cost Basis Days to
Max		 Price at
Max		 Max
Profit ($)		 Max Return (%)
2025-05-16 HCWB Wong Hing C 8,054 7.4500 8,054 7.4500 60,002 4 9.1800 13,934 23.22
2025-05-08 HCWB Wong Hing C 92,500 26.0000 92,500 26.0000 2,405,000
2023-09-14 HCWB Wong Hing C 1,800 2.0782 45 83.1280 3,741
2023-06-02 HCWB Wong Hing C 800 1.5353 20 61.4120 1,228
2023-06-01 HCWB Wong Hing C 800 1.6178 20 64.7120 1,294
2023-05-31 HCWB Wong Hing C 2,000 1.5460 50 61.8400 3,092
2023-05-30 HCWB Wong Hing C 3,000 1.5527 75 62.1080 4,658
2022-09-09 HCWB Wong Hing C 6,000 2.7000 150 108.0000 16,200
2022-09-08 HCWB Wong Hing C 4,000 2.6700 100 106.8000 10,680
2022-09-07 HCWB Wong Hing C 6,000 2.5800 150 103.2000 15,480
2022-09-02 HCWB Wong Hing C 4,000 2.5500 100 102.0000 10,200
2022-06-10 HCWB Wong Hing C 1,520 2.1880 38 87.5200 3,326
2022-06-09 HCWB Wong Hing C 2,000 2.2450 50 89.8000 4,490
2022-06-07 HCWB Wong Hing C 1,000 2.3100 25 92.4000 2,310
2021-08-31 HCWB Wong Hing C 3,830 3.9348 96 157.3920 15,070
2021-08-31 HCWB Wong Hing C 5,830 3.9400 146 157.6000 22,970
2021-08-30 HCWB Wong Hing C 6,000 3.9333 150 157.3320 23,600
2021-08-27 HCWB Wong Hing C 6,000 3.7700 150 150.8000 22,620
2021-08-27 HCWB Wong Hing C 8,000 3.7625 200 150.5000 30,100
2021-08-26 HCWB Wong Hing C 6,500 3.8415 162 153.6600 24,970
2021-07-22 HCWB Wong Hing C 627,500 8.0000 15,688 320.0000 5,020,000

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

HCWB / HCW Biologics Inc. Insider Trades
Insider Sales HCWB / HCW Biologics Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in HCWB / HCW Biologics Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares		 Reported
Price		 Adjusted
Shares		 Adjusted
Price		 Cost Basis Days to
Min		 Price at
Min		 Max Loss
Avoided ($)		 Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

HCWB / HCW Biologics Inc. Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by Hing C Wong as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change		 Share
Price		 Tran
Value		 Remaining
Value
2025-05-20 2025-05-16 4 HCWB HCW Biologics Inc.
Common Stock 		P - Purchase 8,054 501,911 1.63 7.45 60,002 3,739,237
2025-05-09 2025-05-08 4 HCWB HCW Biologics Inc.
Common Stock 		P - Purchase 92,500 493,857 23.05 26.00 2,405,000 12,840,282
2024-02-22 2024-02-20 4 HCWB HCW Biologics Inc.
Common Stock 		A - Award 739,288 16,054,156 4.83 1.40 1,035,003 22,475,818
2023-09-18 2023-09-14 4 HCWB HCW Biologics Inc.
Common Stock 		P - Purchase 1,800 15,314,868 0.01 2.08 3,741 31,827,359
2023-06-02 2023-06-02 4 HCWB HCW Biologics Inc.
Common Stock 		P - Purchase 800 15,313,068 0.01 1.54 1,228 23,510,153
2023-06-02 2023-06-01 4 HCWB HCW Biologics Inc.
Common Stock 		P - Purchase 800 15,312,268 0.01 1.62 1,294 24,772,187
2023-06-01 2023-05-31 4 HCWB HCW Biologics Inc.
Common Stock 		P - Purchase 2,000 15,311,468 0.01 1.55 3,092 23,671,530
2023-06-01 2023-05-30 4 HCWB HCW Biologics Inc.
Common Stock 		P - Purchase 3,000 15,309,468 0.02 1.55 4,658 23,771,011
2022-09-12 2022-09-09 4 HCWB HCW Biologics Inc.
Common Stock 		P - Purchase 6,000 15,306,468 0.04 2.70 16,200 41,327,464
2022-09-12 2022-09-08 4 HCWB HCW Biologics Inc.
Common Stock 		P - Purchase 4,000 15,300,468 0.03 2.67 10,680 40,852,250
2022-09-07 2022-09-07 4 HCWB HCW Biologics Inc.
Common Stock 		P - Purchase 6,000 15,296,468 0.04 2.58 15,480 39,464,887
2022-09-07 2022-09-02 4 HCWB HCW Biologics Inc.
Common Stock 		P - Purchase 4,000 15,290,468 0.03 2.55 10,200 38,990,693
2022-06-13 2022-06-10 4 HCWB HCW Biologics Inc.
Common Stock 		P - Purchase 1,520 15,286,468 0.01 2.19 3,326 33,446,792
2022-06-09 2022-06-09 4 HCWB HCW Biologics Inc.
Common Stock 		P - Purchase 2,000 15,284,948 0.01 2.24 4,490 34,314,708
2022-06-09 2022-06-07 4 HCWB HCW Biologics Inc.
Common Stock 		P - Purchase 1,000 15,282,948 0.01 2.31 2,310 35,303,610
2021-10-07 2021-08-27 4/A HCWB HCW Biologics Inc.
Common Stock 		P - Purchase 8,000 15,270,118 0.05 3.76 30,100 57,453,819
2021-10-07 2021-08-31 4/A HCWB HCW Biologics Inc.
Common Stock 		P - Purchase 5,830 15,281,948 0.04 3.94 22,970 60,210,875
2021-09-10 2021-09-08 4 HCWB HCW Biologics Inc.
Stock Option (Right to Buy) 		A - Award 800,000 800,000
2021-09-02 2021-08-31 4 HCWB HCW Biologics Inc.
Common Stock 		P - Purchase 3,830 15,277,948 0.03 3.93 15,070 60,115,670
2021-08-30 2021-08-30 4 HCWB HCW Biologics Inc.
Common Stock 		P - Purchase 6,000 15,274,118 0.04 3.93 23,600 60,077,688
2021-08-30 2021-08-27 4 HCWB HCW Biologics Inc.
Common Stock 		P - Purchase 6,000 15,268,118 0.04 3.77 22,620 57,560,805
2021-08-30 2021-08-26 4 HCWB HCW Biologics Inc.
Common Stock 		P - Purchase 6,500 15,262,118 0.04 3.84 24,970 58,629,426
2021-07-23 2021-07-22 4 HCWB HCW Biologics Inc.
Series C Redeemable Preferred Stock 		C - Conversion -1,071,428 0 -100.00
2021-07-23 2021-07-22 4 HCWB HCW Biologics Inc.
Series B Redeemable Preferred Stock 		C - Conversion -2,954,285 0 -100.00
2021-07-23 2021-07-22 4 HCWB HCW Biologics Inc.
Series A Redeemable Preferred Stock 		C - Conversion -6,316,691 0 -100.00
2021-07-23 2021-07-22 4 HCWB HCW Biologics Inc.
Common Stock 		P - Purchase 627,500 15,255,618 4.29 8.00 5,020,000 122,044,944
2021-07-23 2021-07-22 4 HCWB HCW Biologics Inc.
Common Stock 		C - Conversion 1,071,428 14,628,118 7.90
2021-07-23 2021-07-22 4 HCWB HCW Biologics Inc.
Common Stock 		C - Conversion 2,954,285 13,556,690 27.86
2021-07-23 2021-07-22 4 HCWB HCW Biologics Inc.
Common Stock 		C - Conversion 6,316,691 10,602,405 147.39
2021-07-19 3 HCWB HCW Biologics Inc.
Common Stock 		4,285,714
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)